Condition

Ascites, Malignant clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Ascites, Malignant clinical trials that are recruiting, at sites in 2 countries (most in China (2), United States (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Ascites, Malignant clinical trials

StudyPhaseWhereStatusRegistered
Anti-PD-1 with chemotherapy and intraperitoneal nab-paclitaxel for untreated advanced gastric cancer with ascites — Hangzhou, Zhejiang Recruiting Oct 2, 2026
Using immune checkpoint inhibitors and zoledronic acid to treat malignant ascites in gastric cancer Phase 1/2 Jinan, Shandong Recruiting Jan 6, 2025
Assessing quality of life and muscle loss in patients with fluid buildup in the abdomen — Philadelphia, Pennsylvania Recruiting Feb 14, 2023

All recruiting trials (3)

Related topics

Ascites HepaticGastric Cancer (GC)

Quick answers

How many Ascites, Malignant clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.